|Articles|March 1, 2020
- Pharmaceutical Executive-03-01-2020
- Volume 40
- Issue 3
Pharmaceutical Executive, March 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
The Multichannel Reach: Balancing the Local and Global Voiceabout 6 years ago
Market Access: From Being to Becomingabout 6 years ago
Consider Data Before It’s a Problemabout 6 years ago
Multichannel Marketing: Integrating Omnichannelabout 6 years ago
Feds Target Biosimilar Anticompetitive Practicesabout 6 years ago
Blood Feud Divides Europe Over Plasma Shortfallsabout 6 years ago
Social Media’s Influence in Messaging Mixabout 6 years ago
Habib Bennaceur: Following the Scienceabout 6 years ago
A Bad Deal with Data?about 6 years ago
Country Report: United Arab EmiratesAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
What Pharma Investors Should Expect in the Current Regulatory Environment
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5